HKSE - Delayed Quote HKD

ESSEX BIO-TECH (1061.HK)

5.090
-0.240
(-4.50%)
At close: June 13 at 4:08:07 PM GMT+8
Currency in HKD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,669,816.770
1,669,816.770
1,736,972.134
1,317,710.616
1,637,659.431
Cost of Revenue
171,154.250
171,154.250
174,943.412
128,381.601
241,892.649
Gross Profit
1,498,662.520
1,498,662.520
1,562,028.722
1,189,329.015
1,395,766.782
Operating Expense
1,143,578.072
1,143,578.072
1,227,612.245
907,872.381
982,886.143
Operating Income
355,084.448
355,084.448
334,416.477
281,456.634
412,880.639
Net Non Operating Interest Income Expense
5,359.105
5,359.105
1,131.225
-2,594.498
636.486
Pretax Income
375,500.231
375,500.231
346,014.427
260,342.780
394,457.378
Tax Provision
68,278.413
68,278.413
70,754.810
34,931.470
48,489.295
Net Income Common Stockholders
307,221.818
307,221.818
275,259.617
225,411.310
345,968.083
Average Dilution Earnings
2,464.692
2,464.692
4,123.105
4,047.963
3,975.631
Diluted NI Available to Com Stockholders
309,686.510
309,686.510
279,382.722
229,459.273
349,943.714
Basic EPS
0.46
0.54
0.48
0.39
0.60
Diluted EPS
0.45
0.53
0.47
0.38
0.58
Basic Average Shares
568,342.525
567,489.139
570,222.501
573,964.430
576,581.460
Diluted Average Shares
593,766.253
582,319.647
595,646.229
599,388.158
602,005.188
Total Expenses
1,314,732.322
1,314,732.322
1,402,555.657
1,036,253.982
1,224,778.792
Net Income from Continuing & Discontinued Operation
307,221.818
307,221.818
275,259.617
225,411.310
345,968.083
Normalized Income
314,694.007
314,694.007
269,155.708
279,007.580
373,942.501
Interest Income
11,446.361
11,446.361
12,343.384
8,877.709
9,860.991
Interest Expense
6,087.256
6,087.256
11,212.159
11,472.207
9,224.505
Net Interest Income
5,359.105
5,359.105
1,131.225
-2,594.498
636.486
EBIT
381,587.487
381,587.487
357,226.586
271,814.987
403,681.883
EBITDA
437,460.441
437,460.441
417,102.896
313,727.924
436,652.436
Reconciled Cost of Revenue
171,154.250
171,154.250
174,943.412
128,381.601
241,892.649
Reconciled Depreciation
55,872.954
55,872.954
59,876.310
41,912.937
32,970.553
Net Income from Continuing Operation Net Minority Interest
307,221.818
307,221.818
275,259.617
225,411.310
345,968.083
Total Unusual Items Excluding Goodwill
-9,132.843
-9,132.843
7,672.904
-32,068.984
-31,895.184
Total Unusual Items
-9,132.843
-9,132.843
7,672.904
-6,238.845
-31,895.184
Normalized EBITDA
446,593.284
446,593.284
409,429.992
319,966.769
468,547.620
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,660.654
-1,660.654
1,568.995
-4,302.853
-3,920.766
12/31/2021 - 6/27/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PHO.OL Photocure ASA
51.10
-1.92%
 
3933.HK The United Laboratories International Holdings Limited
17.320
+0.81%
 
2196.HK Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
16.960
-3.20%
 
FAE.MC Faes Farma, S.A.
4.5300
-1.52%
 
HCM HUTCHMED (China) Limited
16.90
-4.63%
 
ACB.TO Aurora Cannabis Inc.
7.98
-3.62%